Skip to main content

Table 1 Characteristics of the patients at entry

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

  all patients (19 patients) sequence N-A (10 patients) sequence A-N (9 patients)
Gender (F/M) 13/6 7/3 6/3
Age (years) 54.7 ± 9.3 (36–70) 56.2 ± 9.6 (37–69) 53.1 ± 9.2 (36–70)
Height (cm) 168 ± 11 169 ± 9 167 ± 13
Weight (Kg) 86 ± 24 84 ± 24 87 ± 26
Body Mass Index (Kg/m2) 30.3 ± 8.2 29.4 ± 8.2 31.3 ± 8.6
  1. Data are expressed as mean ± SD (min-max range)